Pharma Journalist -

SMi Group reports: Head of HBP Surgery and Co-Founder of MiNA Therapeutics, Nagy Habib discusses the challenges and developments in the RNA industry The RNA therapeutics industry has…
Read More...

Verseau Therapeutics, Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared the company’s investigational new drug (IND) application for its lead investigational…
Read More...

Genprex, Inc. a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, announced that it has expanded…
Read More...

With PURIFY’19, the industry was all agog with the quality of content, quality of delegates, choice of speakers and their topics, expansive venue, lucky draws etc. The upcoming…
Read More...

Genprex, Inc. a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, announced that the U.S. Food and Drug…
Read More...

Pfizer Inc. and BioNTech SE announced that the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) of a booster dose of the Pfizer-BioNTech…
Read More...

WuXi Biologics and ImmuneOncia Therapeutics announced that a Memorandum of Understanding (MOU) was signed to form a strategic partnership in the development and manufacturing of…
Read More...

Novavax, Inc. a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced that it has completed submission of…
Read More...

Eisai Co., Ltd. and Biogen Inc. announced that lecanemab, an investigational anti-amyloid beta (Aβ) protofibril antibody for the treatment of early Alzheimer’s disease (AD), was granted…
Read More...

Novavax, Inc. a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and SK bioscience, Co. Limited, a vaccine…
Read More...